Cultivated in Canada. Delivered to the World.

Cultivated in Canada.
Delivered to the World.

Pharmaceutical-Grade Cannabis.

Northern Green Canada is a federally licensed, EU-GMP certified cannabis producer supplying premium, medical cannabis to international pharmaceutical markets - and trusted Curaleaf products to patients across Canada.

EU-GMP Certified

GACP Certified

Health Canada Licensed Producer

A Curaleaf International Company

Who are we?

Northern Green Canada began as a privately held, Health Canada licensed cannabis producer with a singular focus: growing and processing pharmaceutical-grade medical cannabis to the highest global standards. In 2024, NGC was acquired by Curaleaf International - the world's leading cannabis company - and became part of a powerful global network spanning multiple continents.

Today, NGC operates as Curaleaf’s Canadian production hub, combining the precision and quality of its indoor facility with the scale, logistics, and financial stability of a publicly traded global leader. We are proud to be the first privately held Canadian company to achieve EU-GMP certification — a distinction that sets us apart in every market we serve.

What do we do?

Cultivation

At our licensed indoor facility, we cultivate, harvest, and process pharmaceutical-grade cannabis to the highest global standards. Our clean-room environment preserves the natural terpene profile and product integrity that international markets demand. Every batch is produced under EU-GMP and GACP standards, with full Certificates of Analysis available for all shipments. 

Global Expert

As part of the Curaleaf International network, NGC supplies premium cannabis to licensed pharmaceutical distributors across multiple regions including Germany, the United Kingdom, Poland, Australia, and New Zealand.

Medical Products for Canadian Patients

Curaleaf products, grown and processed by Northern Green Canada, are available to authorized patients across Canada through our partner medical channel MyMedi. Our portfolio offers a range of strains and formats designed for patient efficacy. Prescription through a licensed healthcare practitioner is required.

Our products

Northern Green Canada cultivates a curated selection of premium cannabis strains, available to Canadian patients under the Curaleaf house of brands through authorized medical channels.

Every product is batch-tested at Health Canada-approved laboratories, screened for pesticides, heavy metals, and microbial contaminants, and labeled with verified potency information. Our facility operates under Good Production Practices (GPP) standards -because a patient’s health depends on it.

Our certifications

Built to the Highest Global Standards

EU-GMP

European Union Good Manufacturing Practice NGC was the first privately held Canadian cannabis company to achieve EU-GMP certification. This pharmaceutical-grade standard governs every stage of our production process and is the benchmark required for access to regulated European and international medical markets.

GACP

Good Agricultural and Collection Practices Our cultivation protocols meet GACP standards, ensuring the traceability, consistency, and safety of our cannabis from seed to final product. NGC has operated under GACP practices since 2020.

Health Canada Licensed Producer

We operate fully within the statutory framework of Canada’s Cannabis Act, with all product batches tested by Health Canada-approved laboratories for potency, pesticides, heavy metals, and microbial compliance.

Get in touch

Whether you are an international pharmaceutical distributor, a healthcare provider, or a patient with questions - our team is here to help.

  • 1-866-233-3707
  • ngc.client.services@curaleafint.com
  • info@curaleafint.com